0001415889-24-017448.txt : 20240618
0001415889-24-017448.hdr.sgml : 20240618
20240618170025
ACCESSION NUMBER: 0001415889-24-017448
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240614
FILED AS OF DATE: 20240618
DATE AS OF CHANGE: 20240618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Graham G. Walmsley
CENTRAL INDEX KEY: 0001777517
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39712
FILM NUMBER: 241052756
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 415-801-8100
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Olema Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001750284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 300409740
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 780 BRANNAN STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: (415) 651-3316
MAIL ADDRESS:
STREET 1: 780 BRANNAN STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
4
1
form4-06182024_050620.xml
X0508
4
2024-06-14
0001750284
Olema Pharmaceuticals, Inc.
OLMA
0001777517
Graham G. Walmsley
C/O LOGOS GLOBAL MANAGEMENT LP
1 LETTERMAN DRIVE, BLDG. C, STE C3-350
SAN FRANCISCO
CA
94129
true
false
false
false
0
Stock Option (right to buy)
12.36
2024-06-14
4
A
0
23000
0
A
2034-06-14
Common Stock
23000
23000
D
The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 14, 2024, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.
/s/ Shane Kovacs, Attorney-in-Fact
2024-06-18